Bergamot polyphenol fraction prevents nonalcoholic fatty liver disease via stimulation of lipophagy in cafeteria diet-induced rat model of metabolic syndrome

Journal of Nutritional Biochemistry

Volumn 26, Issue 9, 2015, Pages 938-948

  Parafati, Maddalena ^a,e   Lascala, Antonella ^a   Morittu, Valeria Maria ^a   Trimboli, Francesca ^a   Rizzuto, Antonia ^b   Brunelli, Elvira ^a   Coscarelli, Francesca ^a   Costa, Nicola ^a   Britti, Domenico ^a   Ehrlich, James ^c   Isidoro, Ciro ^d   Mollace, Vincenzo ^a,e   Janda, Elzbieta ^a,e  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b Interregional Research Center for Food Safety and Health (IRC FSH)   (Italy)

^c UNIVERSITY OF CALABRIA   (Italy)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF EASTERN PIEDMONT   (Italy)

Author keywords

Dyslipidemia; Flavonoid; Hypercaloric diet; Lipid droplet fraction; Lipid macroautophagy; NAFLD

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BECLIN 1; BERGAMOT POLYPHENOL FRACTION; BILIRUBIN GLUCURONIDE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; LIPID; LIVER PROTECTIVE AGENT; NITROGEN; POLYPHENOL DERIVATIVE; PROTEIN P62; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UREA; ANTIOBESITY AGENT; BIOLOGICAL MARKER; FAT DROPLET; LC3 PROTEIN, RAT; LIPOTROPIC AGENT; MICROTUBULE ASSOCIATED PROTEIN; PLANT EXTRACT; POLYPHENOL;

AMINOTRANSFERASE BLOOD LEVEL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOPHAGY; BERGAMOT; CELL FRACTIONATION; CITRUS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; ECHOGRAPHY; FOOD INTAKE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HISTOLOGY; LIPID BLOOD LEVEL; LIPID METABOLISM; LIPOPHAGOCYTOSIS; LIVER CELL; LIVER PROTECTION; MALE; METABOLIC SYNDROME X; MORPHOMETRICS; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; RAT; TRIACYLGLYCEROL BLOOD LEVEL; UREA NITROGEN BLOOD LEVEL; WEIGHT GAIN; ADVERSE EFFECTS; AGONISTS; ANIMAL; BLOOD; CHEMISTRY; DIETARY SUPPLEMENT; DISEASE MODEL; FRUIT; HUMAN; ITALY; LIVER; METABOLISM; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZATION; WESTERN DIET; WISTAR RAT;

ANIMALIA; RATTUS;

ANIMALS; ANTI-OBESITY AGENTS; AUTOPHAGY; BIOMARKERS; CITRUS; DIET, WESTERN; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FRUIT; HUMANS; ITALY; LIPID DROPLETS; LIPOTROPIC AGENTS; LIVER; METABOLIC SYNDROME X; MICROTUBULE-ASSOCIATED PROTEINS; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; PLANT EXTRACTS; POLYPHENOLS; RANDOM ALLOCATION; RATS, WISTAR;

EID: 84939575511     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.03.008     Document Type: Article

References (53)

1. Marzuillo P., Miraglia Del Giudice E., Santoro N. Pediatric fatty liver disease: role of ethnicity and genetics. World J Gastroenterol 2014, 20:7347-7355.
2. Mouzaki M., Allard J.P. The role of nutrients in the development, progression, and treatment of nonalcoholic fatty liver disease. J Clin Gastroenterol 2012, 46:457-467.
3. Gaggini M., Morelli M., Buzzigoli E., DeFronzo R.A., Bugianesi E., Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients 2013, 5:1544-1560.
4. Gastaldelli A. Fatty liver disease: the hepatic manifestation of metabolic syndrome. Hypertens Res 2010, 33:546-547.
5. McClain C.J., Barve S., Deaciuc I. Good fat/bad fat. Hepatology 2007, 45:1343-1346.
6. Day C.P. Pathogenesis of steatohepatitis. Best Pract Res Clin Gastroenterol 2002, 16:663-678.
7. Gossard A.A., Lindor K.D. Current therapies for nonalcoholic fatty liver disease. Drugs Today (Barc) 2011, 47:915-922.
8. Ozturk Y., Soylu O.B. Fatty liver in childhood. World J Hepatol 2014, 6:33-40.
9. Sampey B.P., Vanhoose A.M., Winfield H.M., Freemerman A.J., Muehlbauer M.J., Fueger P.T., et al. Cafeteria diet is a robust model of human metabolic syndrome with liver and adipose inflammation: comparison to high-fat diet. Obesity (Silver Spring) 2011, 19:1109-1117.
10. Brandimarti P., Costa-Junior J.M., Ferreira S.M., Protzek A.O., Santos G.J., Carneiro E.M., et al. Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing. J Endocrinol 2013, 219:173-182.
11. Kawano Y., Cohen D.E. Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease. J Gastroenterol 2013, 48:434-441.
12. Liu K., Czaja M.J. Regulation of lipid stores and metabolism by lipophagy. Cell Death Differ 2013, 20:3-11.
13. Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., et al. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
14. Czaja M.J., Ding W.X., Donohue T.M., Friedman S.L., Kim J.S., Komatsu M., et al. Functions of autophagy in normal and diseased liver. Autophagy 2013, 9:1131-1158.
15. Gonzalez-Rodriguez A., Mayoral R., Agra N., Valdecantos M.P., Pardo V., Miquilena-Colina M.E., et al. Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis 2014, 5:e1179.
16. Yang L., Li P., Fu S., Calay E.S., Hotamisligil G.S. Defective hepatic autophagy in obesity promotes ER stress and causes insulin resistance. Cell Metab 2014, 11:467-478.
17. Dagda R.K., Das Banerjee T., Janda E. How Parkinsonian toxins dysregulate the autophagy machinery. Int J Mol Sci 2013, 14:22163-22189.
18. Janda E., Isidoro C., Carresi C., Mollace V. Defective autophagy in Parkinson's disease: role of oxidative stress. Mol Neurobiol 2012, 46:639-661.
19. Mahady S.E., Webster A.C., Walker S., Sanyal A., George J. The role of thiazolidinediones in non-alcoholic steatohepatitis-a systematic review and meta analysis. J Hepatol 2011, 55:1383-1390.
20. Keating S.E., Hackett D.A., George J., Johnson N.A. Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol 2012, 57:157-166.
21. Baur J.A., Pearson K.J., Price N.L., Jamieson H.A., Lerin C., Kalra A., et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006, 444:337-342.
22. Xiao J., Ho C.T., Liong E.C., Nanji A.A., Leung T.M., Lau T.Y., et al. Epigallocatechin gallate attenuates fibrosis, oxidative stress, and inflammation in non-alcoholic fatty liver disease rat model through TGF/SMAD, PI3 K/Akt/FoxO1, and NF-kappa B pathways. Eur J Nutr 2014, 53:187-199.
23. Bahadoran Z., Mirmiran P., Azizi F. Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 2013, 12:43.
24. Mulvihill E.E., Allister E.M., Sutherland B.G., Telford D.E., Sawyez C.G., Edwards J.Y., et al. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes 2009, 58:2198-2210.
25. Nogata Y., Sakamoto K., Shiratsuchi H., Ishii T., Yano M., Ohta H. Flavonoid composition of fruit tissues of citrus species. Biosci Biotechnol Biochem 2006, 70:178-192.
26. Walker R., Janda E., Mollace V. The use of bergamot-derived polyphenol fraction in cardiometabolic risk prevention and its possible mechanisms of action. Polyphenols Hum Health Dis 2014, 2:1085-1103.
27. Di Donna L., De Luca G., Mazzotti F., Napoli A., Salerno R., Taverna D., et al. Statin-like principles of bergamot fruit (Citrus bergamia): isolation of 3-hydroxymethylglutaryl flavonoid glycosides. J Nat Prod 2009, 72:1352-1354.
28. Miceli N., Mondello M.R., Monforte M.T., Sdrafkakis V., Dugo P., Crupi M.L., et al. Hypolipidemic effects of Citrus bergamia Risso et Poiteau juice in rats fed a hypercholesterolemic diet. J Agric Food Chem 2007, 55:10671-10677.
29. Mollace V., Sacco I., Janda E., Malara C., Ventrice D., Colica C., et al. Hypolipemic and hypoglycaemic activity of bergamot polyphenols: from animal models to human studies. Fitoterapia 2011, 82:309-316.
30. Gliozzi M., Walker R., Muscoli S., Vitale C., Gratteri S., Carresi C., et al. Bergamot polyphenolic fraction enhances rosuvastatin-induced effect on LDL-cholesterol, LOX-1 expression and protein kinase B phosphorylation in patients with hyperlipidemia. Int J Cardiol 2013, 170:140-145.
31. Khan H.A. CalcDose: a software for drug dosage conversion using metabolically active mass of animals. Drug Chem Toxicol 2003, 26:51-58.
32. Fernandez-Dominguez I., Echevarria-Uraga J.J., Gomez N., Luka Z., Wagner C., Lu S.C., et al. High-frequency ultrasound imaging for longitudinal evaluation of non-alcoholic fatty liver disease progression in mice. Ultrasound Med Biol 2011, 37:1161-1169.
33. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957, 226:497-509.
34. Ding Y., Zhang S., Yang L., Na H., Zhang P., Zhang H., et al. Isolating lipid droplets from multiple species. Nat Protoc 2013, 8:43-51.
35. Janda E., Parafati M., Aprigliano S., Carresi C., Visalli V., Sacco I., et al. The antidote effect of quinone oxidoreductase 2 inhibitor against paraquat-induced toxicity in vitro and in vivo. Br J Pharmacol 2013, 168:46-59.
36. Novelli E.L., Diniz Y.S., Galhardi C.M., Ebaid G.M., Rodrigues H.G., Mani F., et al. Anthropometrical parameters and markers of obesity in rats. Lab Anim 2007, 41:111-119.
37. Chen B.L., Wang L.T., Huang K.H., Wang C.C., Chiang C.K., Liu S.H. Quercetin attenuates renal ischemia/reperfusion injury via an activation of AMP-activated protein kinase-regulated autophagy pathway. J Nutr Biochem 2014, 25:1226-1234.
38. Lee K.W., Thiyagarajan V., Sie H.W., Cheng M.F., Tsai M.J., Chia Y.C., et al. Synergistic effect of natural compounds on the fatty acid-induced autophagy of activated hepatic stellate cells. J Nutr Biochem 2014, 25:903-913.
39. Pietrocola F., Marino G., Lissa D., Vacchelli E., Malik S.A., Niso-Santano M., et al. Pro-autophagic polyphenols reduce the acetylation of cytoplasmic proteins. Cell Cycle 2012, 11:3851-3860.
40. Thongrakard V., Titone R., Follo C., Morani F., Suksamrarn A., Tencomnao T., et al. Turmeric toxicity in A431 epidermoid cancer cells associates with autophagy degradation of anti-apoptotic and anti-autophagic p53 mutant. Phytother Res 2014, 28(12):1761-1769.
41. Zhou J., Farah B.L., Sinha R.A., Wu Y., Singh B.K., Bay B.H., et al. Epigallocatechin-3-gallate (EGCG), a green tea polyphenol, stimulates hepatic autophagy and lipid clearance. PLoS One 2014, 9:e87161.
42. Klionsky D.J., Abdalla F.C., Abeliovich H., Abraham R.T., Acevedo-Arozena A., Adeli K., et al. Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy 2012, 8:445-544.
43. Gao S., Hu M. Bioavailability challenges associated with development of anti-cancer phenolics. Mini Rev Med Chem 2010, 10:550-567.
44. Rubio L., Macia A., Motilva M.J. Impact of various factors on pharmacokinetics of bioactive polyphenols: an overview. Curr Drug Metab 2014, 15:62-76.
45. Thiam A.R., Farese R.V., Walther T.C. The biophysics and cell biology of lipid droplets. Nat Rev Mol Cell Biol 2013, 14:775-786.
46. Walther T.C., Farese R.V. Lipid droplets and cellular lipid metabolism. Annu Rev Biochem 2012, 81:687-714.
47. Unger E.K., Piper M.L., Olofsson L.E., Xu A.W. Functional role of c-Jun-N-terminal kinase in feeding regulation. Endocrinology 2010, 151:671-682.
48. Suzuki M., Shinohara Y., Ohsaki Y., Fujimoto T. Lipid droplets: size matters. J Electron Microsc (Tokyo) 2011, 60(Suppl. 1):S101-S116.
49. Fromenty B., Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 1997, 26(Suppl. 2):43-53.
50. Kim J., Kundu M., Viollet B., Guan K.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011, 13:132-141.
51. Park S.J., Ahmad F., Philp A., Baar K., Williams T., Luo H., et al. Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases. Cell 2012, 148:421-433.
52. Moskot M., Jakobkiewicz-Banecka J., Kloska A., Smolinska E., Mozolewski P., Malinowska M., et al. Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids. Sci Rep 2015, 5:9378.
53. Moskot M., Montefusco S., Jakobkiewicz-Banecka J., Mozolewski P., Wegrzyn A., Di Bernardo D., et al. The phytoestrogen genistein modulates lysosomal metabolism and transcription factor EB (TFEB) activation. J Biol Chem 2014, 289:17054-17069.